Idexx Laboratories IDXX Deferred revenue, net of current portion
Deferred revenue, net of current portion at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's deferred revenue, net of current portion.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's deferred revenue, net of current portion?
- Idexx Laboratories (IDXX) reported deferred revenue, net of current portion of $32.31M in Q1 2026.
- How has Idexx Laboratories's deferred revenue, net of current portion changed year-over-year?
- Idexx Laboratories's deferred revenue, net of current portion increased by 20.5% year-over-year, from $26.82M to $32.31M.
- What is the long-term trend for Idexx Laboratories's deferred revenue, net of current portion?
- Over 5 years (2020 to 2025), Idexx Laboratories's deferred revenue, net of current portion has grown at a -7.0% compound annual growth rate (CAGR), from $46.16M to $32.18M.
- What does deferred revenue, net of current portion mean?
- This represents the portion of revenue received in advance from customers for goods or services that will be recognized as revenue beyond the next twelve months. For Idexx, this typically relates to long-term service contracts or multi-year software subscriptions for veterinary practice management systems. It reflects future performance obligations that the company is committed to fulfilling over an extended period.